Wegovy Pill 1.5 mg, 30 Tablets: A Medically Supervised Start to Weight Management
Wegovy Pill 1.5 mg, an oral weight loss medication, is the once-daily starting dose of oral semaglutide, a prescription GLP-1 receptor agonist used together with a reduced-calorie diet and more physical activity in adults with obesity or overweight with weight-related health conditions. At Al Thiqa Pharmacy, the medication is dispensed only after a valid prescription is verified, and it is paired with clinical follow-up and nutrition and lifestyle coaching through Wazin program. Sustainable progress comes from the combination, not from the tablet alone.
Quick-facts box:
- Active ingredient: semaglutide 1.5 mg per tablet
- Pack: 30 tablets (one month at the starting dose)
- Dosing: one tablet daily, then wait at least 30 minutes before food, drinks or other oral medicines
- Status: prescription-only; regulator-approved in the UAE (EDE, June 2026)
- Maintenance dose: 25 mg daily after step-up
How GLP-1 medications work
Semaglutide mimics GLP-1, a gut hormone released after meals. It acts in three main ways:
- Appetite signals: it acts on appetite centres in the brain so you feel full sooner and have fewer cravings.
- Gastric emptying: it slows how fast the stomach empties, so fullness lasts longer.
- Blood sugar regulation: it helps the pancreas release insulin when glucose is high and lowers glucagon, which is why people with diabetes need glucose monitoring when starting.
How to take it
- Take one tablet at the same time each day, swallowed whole with a small sip of plain water, on an empty stomach.
- Wait at least 30 minutes before eating, drinking, or taking other oral medicines; otherwise absorption may drop.
- Missed a dose? Skip it and take the next dose the following day. Do not double up.
Who is an eligible candidate
Suitability is always decided by a licensed prescriber. Typical criteria for adults (18+) are:
- BMI of 30 kg/m² or higher (obesity), or BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as high blood pressure, type 2 diabetes, abnormal cholesterol, sleep apnoea, or established heart disease. Calculate your BMI.
- Commitment to a reduced-calorie diet and regular physical activity
Not suitable, or needs specialist advice:
- Personal or family history of medullary thyroid carcinoma
- Allergy to semaglutide or any ingredient
- Pregnancy, planning pregnancy or breastfeeding
- History of pancreatitis, gallbladder disease, severe digestive disease or diabetic eye disease
- Taking other GLP-1 or GIP/GLP-1 medicines, or oral drugs with a narrow dosing window (for example warfarin-type anticoagulants or levothyroxine): the prescriber must review these
Medical supervision and safety protocol
- Clinical evaluation: medical history, current medicines, BMI, blood pressure, and relevant labs by a licensed doctor (free teleconsultation available).
- Prescription verification: a pharmacist validates the prescription, dose, and interactions before dispensing.
- Counselling at dispensing: how to take the tablet, what to expect, when to call.
- Scheduled follow-ups: tolerability, weight, blood pressure, and blood glucose (if diabetic) are reviewed before each dose step-up.
- Side effect plan: most gastrointestinal effects ease over time. Eat smaller, lower-fat meals, stay hydrated, and stop eating when full.
Side Effects
Common side effects may include nausea, diarrhea, constipation, vomiting, abdominal discomfort, headache, tiredness, bloating, heartburn, and hair loss.
Contact your doctor promptly for: severe or persistent stomach pain (possible pancreatitis or gallbladder problems), persistent vomiting or signs of dehydration, a neck lump, trouble swallowing or a hoarse voice, signs of an allergic reaction, or vision changes. Common effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort.
